Healthcare

Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024

NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated…

6 months ago

Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium

Hematology Oncology of Indiana’s M. Sarfraz Nawaz, MD, investigated improvement in approaches to febrile neutropenia in cancer patients Indianapolis Medical…

6 months ago

Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide

Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration Oak Ridge, TN, July 11, 2024 (GLOBE…

6 months ago

Derek Chaves Appointed Chief Financial Officer of Corza Medical

WESTWOOD, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”) is proud to announce the appointment…

6 months ago

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in…

6 months ago

Hydreight Expands Its “At-Home Blood Testing” Solution with More Tests to All 50 States

In a joint-venture with a national laboratory, Hydreight and its medical network are expanding at-home lab tests spanning a range…

6 months ago

Indegene Announces Strategic Collaboration with Microsoft to Help Life Sciences Companies Scale Up Generative AI Adoption and Accelerate Business Impact

PRINCETON, N.J. and BENGALURU, India, July 11, 2024 (GLOBE NEWSWIRE) -- Indegene today announced a strategic collaboration with Microsoft to…

6 months ago

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential

Exclusive global rights secured for development, manufacture and commercialization of FS001, completing final stages of pre-clinical development with first-in-class potentialFS001…

6 months ago

ICPO Foundation partners with the American Hospital Dubai to establish an ICPO Collaborating Center in the Middle East.

This cooperation strengthens global educational standards for radiotheranostics and will scale patient access to a new generation of effective cancer…

6 months ago

Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec

Bagsværd, Denmark, 10 July 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued…

6 months ago